Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

NCT07306624 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Nelmastobart and Docetaxel

Sponsor

STCube, Inc.